Global Open Loop Artificial Pancreas Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Open Loop Artificial Pancreas market size was valued at US$ 1574 million in 2024 and is forecast to a readjusted size of USD 2614 million by 2031 with a CAGR of 7.5% during review period.

Open loop artificial pancreas is a relatively simple but effective medical device for diabetes management. Its core function is to simulate the insulin secretion mechanism of healthy pancreas. Unlike closed-loop systems, open-loop artificial pancreas does not have blood glucose sensors, but is mainly composed of two core parts: a microcomputer and an insulin injection pump. This system design simplifies its structure, reduces its size, and makes it easier for patients to carry and use. The operating mechanism of open-loop artificial pancreas is based on preset programs rather than real-time blood glucose monitoring data. The patient's blood glucose concentration data needs to be manually input into the system, and the microcomputer calculates the insulin dose and rate parameters that need to be infused based on these input data and preset algorithms. Subsequently, the insulin injection pump automatically injects the corresponding amount of insulin into the patient's body according to the calculated parameters.

The global open loop artificial pancreas market has maintained a growth trend in recent years. With the acceleration of the aging process of the population and the change of lifestyle, the number of patients with diabetes has increased rapidly, providing a huge potential demand for artificial pancreas. The technological breakthroughs in the field of artificial pancreas are mainly reflected in miniaturization, intelligence, and materials science, which indirectly promote the improvement and upgrading of open-loop systems. The changes in medical policies and reimbursement systems have a profound impact on the market landscape. In many developed countries, artificial pancreas is included in the coverage of medical insurance, which greatly reduces the economic burden on patients and promotes the increase of market penetration. With the popularization of health education and the wide spread of medical information, diabetes patients began to seek more accurate and convenient blood glucose management solutions. The open-loop artificial pancreas is between traditional injection and fully automated closed-loop systems, balancing performance and price, and has become the choice of many patients. The global market competition pattern is relatively clear, with multiple companies engaging in fierce competition. Tandem Diabetes Care, Johnson&Johnson, Medtronic and other companies form the forefront of the industry. They occupy an important position with their strong research and development capabilities, mature production capabilities, and extensive sales network. The focus of competition between enterprises is gradually shifting from simple device performance to the provision of overall solutions, including multiple dimensions such as supporting software, data services, and user experience. Open loop artificial pancreas is a relatively mature product, and its technological development mainly focuses on improving the accuracy, reliability, and user friendliness of the system, while striving to reduce production costs and maintenance complexity. The introduction of intelligent functions and algorithm optimization is changing the user experience of traditional open-loop systems. The development of future biotechnology may bring about new insulin delivery mechanisms, and breakthroughs in materials science may enable longer lasting implantable components, reducing equipment maintenance requirements. The advancement of energy technology may give rise to ultra long battery life or even self powered systems, greatly improving user convenience. New products such as patch insulin delivery devices and wearable integrated devices will further simplify the usage process and reduce interference with patients' daily lives. In addition, integration with the digital health ecosystem, innovation in manufacturing processes, and finding exclusive market positioning are also the development trends of future products.

This report is a detailed and comprehensive analysis for global Open Loop Artificial Pancreas market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Open Loop Artificial Pancreas market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031

Global Open Loop Artificial Pancreas market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031

Global Open Loop Artificial Pancreas market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031

Global Open Loop Artificial Pancreas market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Open Loop Artificial Pancreas

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Open Loop Artificial Pancreas market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Insulet, Tandem Diabetes Care, Johnson And Johnson, Abbott Laboratories, Ypsomed, Dexcom, Medtronic, Medtrum Technologies, MicroTech Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Open Loop Artificial Pancreas market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Basic Insulin Pump System
CGM Insulin Pump Linkage System
Threshold Pause System

Market segment by Application
Type 1 Diabetes Management
Type 2 Diabetes Intensive Treatment
Clinical Research Transitional Stage

Major players covered
Roche
Insulet
Tandem Diabetes Care
Johnson And Johnson
Abbott Laboratories
Ypsomed
Dexcom
Medtronic
Medtrum Technologies
MicroTech Medical
Sansure Medical
Medlinket Medical Technology
SiBionics

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Open Loop Artificial Pancreas product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Open Loop Artificial Pancreas, with price, sales quantity, revenue, and global market share of Open Loop Artificial Pancreas from 2020 to 2025.

Chapter 3, the Open Loop Artificial Pancreas competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Open Loop Artificial Pancreas breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Open Loop Artificial Pancreas market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Open Loop Artificial Pancreas.

Chapter 14 and 15, to describe Open Loop Artificial Pancreas sales channel, distributors, customers, research findings and conclusion.